UMEM Educational Pearls - Gastrointestional

Title: Suspected Variceal Bleed

Category: Gastrointestional

Keywords: Variceal Bleed (PubMed Search)

Posted: 3/11/2008 by Rob Rogers, MD (Updated: 11/22/2024)
Click here to contact Rob Rogers, MD

 Medical Regimen for Suspected Variceal Bleed

To review what Dr. Bond and Dr. Winters have already posted:

Three medical therapies have been shown to be effective in patients with severe upper GI bleed thought to be due to esophageal varices:

  • Octreatide: 50-100 ug bolus followed by 50 ug/hour. Has been shown to lower the rebleeding rate substantially. Even if varices have not been confirmed by endoscopy, Octreatide has also been shown to be effective in ulcer bleeding as well.
  • Antibiotics (3rd generation Cephalosporin): Have been to lower the rebleeding rate in variceal bleeding. 
  • Intravenous Proton Pump Inhibitor: Remember that a liver patient is as likely to have a non-variceal source of bleeding (ulcer), so add a PPI drip. Raising the pH stabilizes clot. Without endoscopy, you don't know if they have an ulcer or another etiology.

Most of our gastroenterologists recommend this regimen (all three therapies)

Other things to consider:

  • Platelets, FFP
  • Intubate EARLY-most endoscopists will want the airway protected prior to the scope.
  • Don't be too aggressive with blood replacement/IVF: The gastroenterologist don't want these patients too resuscitated with blood products. Certainly don't aim for a Hct >30.


Title: Volvulus Quick Facts

Category: Gastrointestional

Keywords: Volvulus, Cause, (PubMed Search)

Posted: 11/17/2007 by Michael Bond, MD (Updated: 11/22/2024)
Click here to contact Michael Bond, MD

Volvulus Quick Facts

  • Volvulus causes 10-15% of large bowel obstructions and occurs most commonly in the elderly.
  • The most common type of volvulus is sigmoid volvulus.
  • Midgut volvulus is most common in the neonatal period.
  • Cecal volvulus:
    • Occurs in all ages, but most commonly in the 25- to 35-year-old age group
    • Associated with:
      • previous abdominal surgeries
      • young, healthy marathon runners.
  • Sigmoid volvulus most commonly occurs in two groups of individuals:
    • Inactive elderly persons with a history of severe chronic constipation
    • Patients with severe psychiatric or neurologic disease.


Title: Gastrointestional Bleeding

Category: Gastrointestional

Keywords: Gi Bleed, Diveriticular, Bleed, (PubMed Search)

Posted: 9/22/2007 by Michael Bond, MD (Updated: 11/22/2024)
Click here to contact Michael Bond, MD

Gastrointestional Bleeding Pearls. [Quick Facts]
  • Peptic ulcer disease has 2 main etiologies: 1) Helicobacter pylorus infection and 2) NSAID use. Zollinger Ellison Syndrome causes 1% of peptic ulcer disease.
  • Hemorrhage is the most common complication of peptic ulcer disease, occurring in 15% of patients
  • 25% of patients over the age of 60 years have an AV malformation.
  • The most common cause of significant lower GI bleeding in the elderly is diverticulosis or angiodysplasia. That typically presents as painless bright red rectal bleeding.
  • AV malformations are the number 2 cause of massive lower gastrointestinal hemorrhage.
  • Rectal bleeding following AAA repair is from aortoenteric fistula until proven otherwise.


Title: Medical Management of Upper GI Bleeds

Category: Gastrointestional

Keywords: Peptic Ulcer Disease, Omeprazole, Bleeding (PubMed Search)

Posted: 8/19/2007 by Michael Bond, MD (Updated: 11/22/2024)
Click here to contact Michael Bond, MD

Medical Management of Upper GI bleeds. Peptic Ulcer Disease: Proton pump inhibitors are the main stay of therapy. Use is based on the observation that pH over 6 is required for platelet aggregation whereas pH below 5 results in clot lysis. High dose IV therapy should be reserved with those that have high risk stigmata of rebleeding as seen on endoscopy. Regular dose IV or PO omeprazole can be used in most patients. Variceal Bleeding: Consider octreatide (50 mcg bolus followed by 50 mcg/hr IV) and non-selective beta blocker therapy to reduce bleeding. Human recombinant activated factor VII has gotten a lot of press lately though it did not reduce the risk of death at either 5 or 42 days in patients with liver related GI bleeds.A Wong T. The management of upper gastrointestinal haemorrhage. [Review] [31 refs] [Journal Article. Review] Clinical Medicine. 6(5):460-4, 2006 Sep-Oct. Marti-Carvajal AJ. Salanti G. Marti-Carvajal PI. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. [Review] [45 refs] [Journal Article. Review] Cochrane Database of Systematic Reviews. (1):CD004887, 2007. Martins NB. Wassef W. Upper gastrointestinal bleeding. [Review] [87 refs] [Journal Article. Review] Current Opinion in Gastroenterology. 22(6):612-9, 2006 Nov.